These medications represent one component of cardiovascular risk management, not a standalone solution
43 percent of participants achieved a 5 percent or greater reduction in body weight (compared to 19 percent on placebo)
In some situations, bariatric surgery may be considered for patients meeting specific criteria, particularly those with BMI 40 kg/m or 35 kg/m with obesity-related complications, as outlined in NICE guidance
Hormone signalling : Some users speculate GLP-1 pathways themselves may influence reproductive hormones
Whats a good starting exercise program
Why the benefits of GLP-1 medications outweigh the risks GLP-1 drugs like Ozempic and Mounjaro offer life-changing health outcomes: 1020% weight loss Better control of type 2 diabetes Lower blood pressure and cholesterol Reduced risk of heart disease, stroke, and kidney damage For most patients, these benefits outweigh the very low and uncertain risk of pancreatitis